Skip to content

Therapeutic effect of Buxu Jiedu Huayu Decoction on primary thrombocytosis

Therapeutic effect of Buxu Jiedu Huayu Decoction on primary thrombocytosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003841
Enrollment
Unknown
Registered
2020-08-29
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary thrombocytosis

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old, male and female; 2. Patients who met the above diagnostic criteria; 3. Patients who have no history of allergy to the drugs used in this study and can persist in treatment for at least 3 months.

Exclusion criteria

Exclusion criteria: (1) Patients with mental illness; (2) Patients with active hepatitis, venereal disease and other infectious diseases; (3) Patients with other blood system diseases; (4) Patients with severe cardiovascular disease, liver and kidney disease; (5) Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Bcl-2 level;Platelet aggregation function;platelet count;

Secondary

MeasureTime frame
renal function;liver function;blood lipids;Two and a half hepatitis B;

Countries

China

Contacts

Public ContactJianqing Deng

Shanghai Municipal Hospital of Traditional Chinese Medicine

djq_8313@163.com+86 13661955013

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026